Pharmacological treatment in Parkinson's disease: Effects on gait
نویسندگان
چکیده
منابع مشابه
Treatment with pharmacological agents in peripheral arterial disease patients does not result in biomechanical gait changes.
Pharmacological treatment has been used to alleviate the claudication symptoms and improve walking performance in peripheral arterial disease (PAD) patients. However, the effects of claudication treatments on gait mechanics have not been objectively identified with biomechanical techniques. For this study, 20 PAD patients were assigned to take either pentoxifylline (n=11) or cilostazol (n=9), t...
متن کاملEffects of subthalamic nucleus stimulation and levodopa treatment on gait abnormalities in Parkinson disease.
BACKGROUND Stimulation of the subthalamic nucleus is proposed for the treatment of patients presenting with severe Parkinson disease. The effect on gait is not clearly established. OBJECTIVES To evaluate objectively the influence of bilateral subthalamic nucleus stimulation on gait in Parkinson disease and to compare it with the effects of levodopa treatment. METHODS Ten patients underwent ...
متن کاملPharmacological treatment of Alzheimer's Disease.
BACKGROUND AND AIMS The treatment of Alzheimer's disease (AD) is a challenge for physician, families, and patients. An individualized, multimodal treatment plan addressing the treatment of cognitive, behavioural and functional decline is essential. Aim of the paper is to describe the principal components of the treatment plan of AD patients. METHODS A review of the recent literature was perfo...
متن کاملPharmacological treatment of Parkinson’s disease
For the past 30 years levodopa (LD) has been the pharmacological standard of care for treating idiopathic Parkinson’s disease (PD), a neurodegenerative disease of the central nervous system. LD is a pharmacologically inactive precursor, which is converted enzymatically to the neurotransmitter dopamine by a declining population of neurons in the substantia nigra, the most important site of the p...
متن کاملPharmacological treatment of Parkinson's disease.
Parkinson’s disease is a neurodegenerative disorder of unknown cause. Age is the most consistent risk factor and incidence in the general population over 75 years of age is 254:100 000. With an aging population the management of Parkinson’s disease is likely to prove an increasingly important and challenging aspect of medical practice. Classically Parkinson’s disease presents with resting tremo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Parkinsonism & Related Disorders
سال: 2016
ISSN: 1353-8020
DOI: 10.1016/j.parkreldis.2016.07.006